Cleared Traditional

K191346 - Blackrock NeuroCoG Subdural Cortical Electrodes (Strips and Grids) (FDA 510(k) Clearance)

Feb 2020
Decision
270d
Days
Class 2
Risk

K191346 is an FDA 510(k) clearance for the Blackrock NeuroCoG Subdural Cortical Electrodes (Strips and Grids). This device is classified as a Electrode, Cortical (Class II - Special Controls, product code GYC).

Submitted by Blackrock Microsystems (Salt Lake City, US). The FDA issued a Cleared decision on February 14, 2020, 270 days after receiving the submission on May 20, 2019.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1310.

Submission Details

510(k) Number K191346 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 2019
Decision Date February 14, 2020
Days to Decision 270 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GYC - Electrode, Cortical
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1310